Rapid Care INC
Rapid Care INC was paid $4.22M by Medicaid between Jan 2018 and Dec 2024, across 42 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoRAPID CARE INC
ALBERTVILLE, AL 35950
ALBERTVILLE, AL 35950
33aNPI1376534529assigned 11/04/2005
33bProvider typeLegal Medicine
28Total paid$4.22M
24GClaims150,479
24DCodes billed42
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Legal Medicine providers in Alabama
Rank by total paid#1 of 8
Median peer was paid$159K
This provider vs. median27×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 19,204 | $539K | |
| 2019 | 21,466 | $587K | |
| 2020 | 19,571 | $610K | |
| 2021 | 25,927 | $783K | |
| 2022 | 27,293 | $789K | |
| 2023 | 23,855 | $595K | |
| 2024incomplete | 13,163 | $315K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 40,365 | 34,068 | $1.89M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 23% | 19,172 | 17,416 | $959K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 12% | 7,720 | 6,947 | $510K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 3.8% | 7,325 | 6,535 | $160K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.3% | 18,024 | 16,343 | $140K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2.6% | 11,957 | 6,373 | $111K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.0% | 10,313 | 9,103 | $85K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.4% | 5,097 | 4,620 | $59K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.3% | 1,855 | 1,730 | $54K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.1% | 941 | 865 | $45K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 569 | 513 | $42K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 2,540 | 2,310 | $39K |
30 more codes
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 4,689 | $30K |
| 99243 | <1% | 198 | $21K | |
| 93000 | <1% | 1,138 | $17K | |
| 82947 | <1% | 3,378 | $10K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,734 | $9K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 125 | $6K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 426 | $6K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,522 | $6K |
| 81002 | <1% | 2,338 | $6K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 64 | $5K |
| 74018 | <1% | 206 | $3K | |
| J2010 | Injection, lincomycin hcl, up to 300 mg | <1% | 119 | $2K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 43 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 13 | $2K |
| 80305 | <1% | 80 | $785.25 | |
| 0012A | <1% | 15 | $520.00 | |
| 72100 | <1% | 27 | $451.56 | |
| 0011A | <1% | 14 | $440.00 | |
| 70220 | <1% | 15 | $420.00 | |
| 90656 | <1% | 19 | $331.03 | |
| 72040 | <1% | 13 | $243.00 | |
| 90756 | <1% | 13 | $227.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 379 | $225.43 |
| 81025 | <1% | 60 | $126.00 | |
| 96127 | <1% | 220 | $3.27 | |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 207 | $0.00 |
| 99080 | 0% | 370 | $0.00 | |
| 3078F | 0% | 16 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 51 | $0.00 |
| 3074F | 0% | 109 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAUSTIN, JAMES (OWNER)